Literature DB >> 21728856

Evaluation of the efficacy of gallium maltolate for chemoprophylaxis against pneumonia caused by Rhodococcus equi infection in foals.

M Keith Chaffin1, Noah D Cohen, Ronald J Martens, Michael O'Conor, Lawrence R Bernstein.   

Abstract

OBJECTIVE: To determine the chemoprophylactic effect of gallium maltolate on the cumulative incidence of pneumonia caused by Rhodococcus equi infection in foals. ANIMALS: 483 foals born and raised on 12 equine breeding farms with a history of endemic R equi infections. PROCEDURES: Group 1 foals were treated with a placebo and group 2 foals were treated with gallium maltolate (approx 30 mg/kg, PO, q 24 h) during the first 2 weeks after birth. Foals were monitored for development of pneumonia attributable to R equi infection and for adverse effects of gallium maltolate.
RESULTS: There were no significant differences in the cumulative incidence of R equi pneumonia among the 2 groups. CONCLUSIONS AND CLINICAL RELEVANCE: Chemoprophylaxis via gallium maltolate administered orally at approximately 30 mg/kg daily for the first 2 weeks after birth failed to reduce the cumulative incidence of pneumonia attributable to R equi infection among foals on breeding farms with endemic R equi infections. Further investigation is needed to identify strategies for control of R equi infections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21728856     DOI: 10.2460/ajvr.72.7.945

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  7 in total

1.  PNAG-specific equine IgG1 mediates significantly greater opsonization and killing of Prescottella equi (formerly Rhodococcus equi) than does IgG4/7.

Authors:  Joana N Rocha; Lawrence J Dangott; Waithaka Mwangi; Robert C Alaniz; Angela I Bordin; Colette Cywes-Bentley; Sara D Lawhon; Suresh D Pillai; Jocelyne M Bray; Gerald B Pier; Noah D Cohen
Journal:  Vaccine       Date:  2019-01-26       Impact factor: 3.641

2.  Effect of Macrolide and Rifampin Resistance on the Fitness of Rhodococcus equi.

Authors:  Jennifer M Willingham-Lane; Londa J Berghaus; Roy D Berghaus; Kelsey A Hart; Steeve Giguère
Journal:  Appl Environ Microbiol       Date:  2019-03-22       Impact factor: 4.792

3.  Clinicopathological and radiographic features in 40 cats diagnosed with pulmonary and cutaneous Rhodococcus equi infection (2012-2018).

Authors:  Muhammad Waseem Aslam; Seng Fong Lau; Chelly Sze Lee Chin; Nur Indah Ahmad; Nor-Alimah Rahman; Krishnammah Kuppusamy; Sharina Omar; Rozanaliza Radzi
Journal:  J Feline Med Surg       Date:  2019-11-14       Impact factor: 2.015

4.  Assessment of listing and categorisation of animal diseases within the framework of the Animal Health Law (Regulation (EU) No 2016/429): antimicrobial-resistant Rhodococcus equi in horses.

Authors:  Søren Saxmose Nielsen; Dominique Joseph Bicout; Paolo Calistri; Elisabetta Canali; Julian Ashley Drewe; Bruno Garin-Bastuji; José Luis Gonzales Rojas; Christian Gortázar; Mette Herskin; Virginie Michel; Miguel Ángel Miranda Chueca; Barbara Padalino; Paolo Pasquali; Helen Clare Roberts; Hans Spoolder; Karl Ståhl; Antonio Velarde; Arvo Viltrop; Christoph Winckler; Francesca Baldinelli; Alessandro Broglia; Lisa Kohnle; Julio Alvarez
Journal:  EFSA J       Date:  2022-02-02

5.  Randomized, controlled trial comparing Rhodococcus equi and poly-N-acetyl glucosamine hyperimmune plasma to prevent R equi pneumonia in foals.

Authors:  Susanne K Kahn; Colette Cywes-Bentley; Glenn P Blodgett; Nathan M Canaday; Carly E Turner-Garcia; Patricia Flores-Ahlschwede; Laurie L Metcalfe; Mark Nevill; Mariana Vinacur; Patrick J Sutter; Sarah C Meyer; Angela I Bordin; Gerald B Pier; Noah D Cohen
Journal:  J Vet Intern Med       Date:  2021-11-05       Impact factor: 3.333

Review 6.  Genetic Susceptibility to Rhodococcus equi.

Authors:  C M McQueen; S V Dindot; M J Foster; N D Cohen
Journal:  J Vet Intern Med       Date:  2015-09-04       Impact factor: 3.333

7.  Clinical Assessment of a Point-of-Care Serum Amyloid A Assay in Foals with Bronchopneumonia.

Authors:  S Giguère; L J Berghaus; C D Miller
Journal:  J Vet Intern Med       Date:  2016-06-14       Impact factor: 3.333

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.